文献速递脑血管病

急性M2闭塞伴轻度神经功能缺损卒中患者的治疗与结局

Treatment and Outcome in Stroke Patients With Acute M2 Occlusion and Minor Neurological Deficits.
PubMed 文献 · Stroke · 2021-01-26

该研究回顾性纳入2005年至2020年伯尔尼卒中中心连续收治的169例急性大脑中动脉M2段闭塞且NIHSS≤5分的静脉溶栓(IVT)合格患者,比较仅IVT与血管内治疗(EVT,含动脉溶栓和机械取栓±IVT)以及仅IVT与仅机械取栓(MT)的结局。结果显示EVT(±IVT)与仅IVT、仅MT与仅IVT在良好结局(mRS 0-2)上均无显著差异,但仅分析2015年后治疗患者时EVT组3个月mRS位移显著更优。

要点

  • M2闭塞伴轻度缺损患者中,EVT(±IVT)与仅IVT的3个月良好结局无显著差异。
  • 仅MT与仅IVT相比,良好结局同样无显著差异。
  • 2015年后治疗的患者中,EVT组3个月mRS位移显著优于仅IVT组。

核心结论

  • 在M2段闭塞伴轻度神经功能缺损的卒中患者中,仅IVT与EVT(±IVT)以及仅IVT与仅MT的有效性相似。
  • 仅考虑2015年后治疗的患者时,EVT可能带来获益。

研究设计与样本

  • 回顾性队列研究,纳入2005年1月至2020年1月伯尔尼卒中中心连续收治的急性M2段闭塞且NIHSS≤5分的IVT合格患者,共169例(38.5%女性,中位年龄70.2岁)。

主要发现

  • 84例(49.7%)仅接受IVT,85例(50.3%)接受EVT(±IVT),其中39例(45.9%)仅接受MT。
  • 与仅IVT相比,EVT组良好结局(mRS 0-2)的调整OR为0.96(调整P=0.935),仅MT组调整OR为1.12(调整P=0.547),均无显著差异。
  • 仅分析2015年后治疗的患者,EVT组3个月mRS位移显著优于仅IVT组(调整P=0.032)。

关键数值与推荐

  • 良好结局定义为3个月mRS评分0-2分。
  • 入组标准为急性M2段闭塞、NIHSS评分≤5分且符合IVT条件。

临床怎么用

  • 对于M2段闭塞伴轻度神经功能缺损的患者,仅IVT与EVT(±IVT)或仅MT的总体疗效相似,临床决策需个体化。
  • 2015年后治疗的患者中EVT可能带来额外获益,提示随技术或患者选择变化,EVT的作用可能提升。

局限性

  • 本研究为回顾性单中心队列研究,非随机对照试验。
  • 样本量有限(169例),EVT组中仅MT亚组样本较小(39例)。
  • 标准结局量表(mRS、NIHSS)未充分评估神经认知、生活质量及NIHSS子项,需更精细的评价工具。
  • 作者指出该领域亟需纳入影像学参数的随机对照试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Treatment in stroke patients with M2 segment occlusion of the middle cerebral artery presenting with mild neurological deficits is a matter of debate. The main purpose was to compare the outcome in patients with a minor stroke and a M2 occlusion. METHODS: Consecutive intravenous thrombolysis (IVT) eligible patients admitted to the Bernese stroke center between January 2005 and January 2020 with acute occlusion of the M2 segment and National Institutes of Health Stroke Scale score ≤5 were included. Outcome was compared between IVT only versus endovascular therapy (EVT) including intra-arterial thrombolysis and mechanical thrombectomy (MT; ±IVT) and between IVT only versus MT only. RESULTS: Among 169 patients (38.5% women, median age 70.2 years), 84 (49.7%) received IVT only and 85 (50.3%) EVT (±IVT), the latter including 39 (45.9%) treated with MT only. Groups were similar in sex, age, vascular risk factors, event cause, or preevent independency. Compared with IVT only, there was no difference in favorable outcome (modified Rankin Scale score, 0-2) for EVT (adjusted odds ratio, 0.96; adjusted P=0.935) or for MT only (adjusted odds ratio, 1.12; adjusted P=0.547) groups. Considering only patients treated after 2015, there was a significantly better 3-month modified Rankin Scale shift (adjusted P=0.032) in the EVT compared with the IVT only group. CONCLUSIONS: Our study demonstrates similar effectiveness of IVT only versus EVT (±IVT), and of IVT only versus MT only in patients with peripheral middle cerebral artery occlusions and minor neurological deficits and indicates a possible benefit of EVT considering only patients treated after 2015. There is an unmet need for randomized controlled trials in this stroke field, including imaging parameters, and more sophisticated evaluation of National Institutes of Health Stroke Scale score subitems, neurocognition, and quality of life neglected by the standard outcome scales such as modified Rankin Scale and National Institutes of Health Stroke Scale score.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Dobrocky T, Piechowiak EI, Volbers B, et al. Treatment and Outcome in Stroke Patients With Acute M2 Occlusion and Minor Neurological Deficits. Stroke. 2021. PMID: 33494637. doi:10.1161/STROKEAHA.120.031672

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。